Peregrine Pharmaceuticals | 销售成本

Cost Of Sales 更改 日
Amgen USD 3.11B 1.31B 2023-12
AstraZeneca USD 2.06B 91M 2023-09
GlaxoSmithKline GBP 2.24B 343M 2023-09
MannKind USD 18.07M 3.81M 2023-12
Repligen USD 88.14M 6.21M 2023-12
Roche Holding CHF 7.62B 1.33B 2023-06



Peregrine Pharmaceuticals 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.